Want to see IL:HMGS full AI Analyst Report?
Homebiogas (HMGS) Ratios
Homebiogas Ratios
IL:HMGS's free cash flow for Q2 2026 was $-1.66M. For the 2026 fiscal year, IL:HMGS's free cash flow was decreased by $-44.53K and operating cash flow was $-1.61M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.13 | 2.36 | 4.08 | 4.30 | 9.50 |
| Quick Ratio | 1.63 | 1.94 | 3.67 | 3.88 | 9.01 |
| Cash Ratio | 1.04 | 1.15 | 2.61 | 3.27 | 8.47 |
| Solvency Ratio | -1.77 | -2.60 | -1.87 | -2.71 | -1.42 |
| Operating Cash Flow Ratio | -1.29 | -1.83 | -3.02 | -3.38 | -2.71 |
| Short-Term Operating Cash Flow Coverage | -17.00 | 0.00 | -661.44 | -723.00 | 0.00 |
| Net Current Asset Value | $ 1.84M | $ 2.58M | $ 8.93M | $ 9.49M | $ 23.72M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.06 | 0.10 | 0.08 | 0.06 |
| Debt-to-Equity Ratio | 0.14 | 0.10 | 0.14 | 0.11 | 0.07 |
| Debt-to-Capital Ratio | 0.12 | 0.09 | 0.12 | 0.10 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.87 | 1.67 | 1.38 | 1.36 | 1.20 |
| Debt Service Coverage Ratio | -19.34 | 0.00 | -619.56 | -875.25 | -56.73 |
| Interest Coverage Ratio | -79.77 | 0.00 | 0.00 | 0.00 | -100.78 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.02 | 0.09 | 0.08 | 0.11 |
| Net Debt to EBITDA | 0.42 | 0.29 | 0.73 | 0.68 | 3.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.76% | 14.60% | 32.02% | 28.46% | 9.43% |
| EBIT Margin | -130.39% | -352.47% | -230.64% | -318.59% | -328.57% |
| EBITDA Margin | -120.15% | -313.04% | -205.09% | -297.72% | -307.74% |
| Operating Profit Margin | -132.54% | -361.90% | -225.79% | -195.53% | -548.15% |
| Pretax Profit Margin | -132.05% | -357.95% | -234.53% | -322.40% | -334.00% |
| Net Profit Margin | -132.47% | -358.14% | -234.63% | -322.57% | -334.85% |
| Continuous Operations Profit Margin | -132.47% | -358.14% | -234.63% | -322.57% | -334.85% |
| Net Income Per EBT | 100.31% | 100.05% | 100.04% | 100.05% | 100.25% |
| EBT Per EBIT | 99.63% | 98.91% | 103.87% | 164.88% | 60.93% |
| Return on Assets (ROA) | -79.24% | -114.68% | -58.34% | -77.30% | -24.75% |
| Return on Equity (ROE) | -148.24% | -191.05% | -80.76% | -105.39% | -29.59% |
| Return on Capital Employed (ROCE) | -123.88% | -165.47% | -68.52% | -56.75% | -44.60% |
| Return on Invested Capital (ROIC) | -114.13% | -161.87% | -66.27% | -55.05% | -44.08% |
| Return on Tangible Assets | -79.24% | -127.99% | -64.05% | -86.30% | -26.10% |
| Earnings Yield | -37.42% | -49.40% | -46.86% | -43.00% | -12.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.80 | 2.82 | 13.13 | 3.69 | 4.24 |
| Payables Turnover | 6.47 | 9.94 | 2.95 | 3.20 | 1.85 |
| Inventory Turnover | 2.39 | 2.20 | 2.26 | 2.34 | 1.50 |
| Fixed Asset Turnover | 3.67 | 1.96 | 1.43 | 1.65 | 0.94 |
| Asset Turnover | 0.60 | 0.32 | 0.25 | 0.24 | 0.07 |
| Working Capital Turnover Ratio | 1.14 | 0.37 | 0.44 | 0.25 | 0.15 |
| Cash Conversion Cycle | 226.64 | 258.24 | 65.37 | 140.92 | 132.78 |
| Days of Sales Outstanding | 130.28 | 129.21 | 27.80 | 98.92 | 86.18 |
| Days of Inventory Outstanding | 152.73 | 165.76 | 161.16 | 155.96 | 243.39 |
| Days of Payables Outstanding | 56.37 | 36.73 | 123.59 | 113.96 | 196.79 |
| Operating Cycle | 283.02 | 294.97 | 188.96 | 254.88 | 329.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.09 | -0.19 | -0.46 | -0.59 | -0.44 |
| Free Cash Flow Per Share | -0.09 | -0.24 | -0.49 | -0.65 | -0.57 |
| Dividend Paid and CapEx Coverage Ratio | -249.54 | -4.39 | -19.38 | -9.66 | -3.48 |
| Capital Expenditure Coverage Ratio | -249.54 | -4.39 | -19.38 | -9.66 | -3.48 |
| Operating Cash Flow Coverage Ratio | -6.22 | -9.60 | -5.42 | -7.07 | -4.19 |
| Operating Cash Flow to Sales Ratio | -0.78 | -1.72 | -2.19 | -2.46 | -3.36 |
| Free Cash Flow Yield | -22.05% | -29.06% | -46.01% | -36.20% | -15.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.65 | -2.02 | -2.13 | -2.33 | -8.07 |
| Price-to-Sales (P/S) Ratio | 3.54 | 7.25 | 5.01 | 7.50 | 27.01 |
| Price-to-Book (P/B) Ratio | 3.96 | 3.87 | 1.72 | 2.45 | 2.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.54 | -3.44 | -2.17 | -2.76 | -6.25 |
| Price-to-Operating Cash Flow Ratio | -4.55 | -4.22 | -2.29 | -3.05 | -8.05 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | 0.10 | 0.06 | -0.03 | -1.69 |
| Enterprise Value Multiple | -2.53 | -2.03 | -1.72 | -1.84 | -5.63 |
| Enterprise Value | 9.51M | 16.70M | 17.00M | 25.70M | 42.99M |
| EV to EBITDA | -2.53 | -2.03 | -1.72 | -1.84 | -5.63 |
| EV to Sales | 3.04 | 6.35 | 3.52 | 5.47 | 17.32 |
| EV to Free Cash Flow | -3.89 | -3.01 | -1.53 | -2.01 | -4.01 |
| EV to Operating Cash Flow | -3.91 | -3.70 | -1.61 | -2.22 | -5.16 |
| Tangible Book Value Per Share | 0.12 | 0.18 | 0.54 | 0.67 | 1.45 |
| Shareholders’ Equity Per Share | 0.11 | 0.21 | 0.62 | 0.73 | 1.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.12 | 0.11 | 0.21 | 0.24 | 0.13 |
| Net Income Per Share | -0.16 | -0.40 | -0.50 | -0.77 | -0.44 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.02 | 1.02 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.07 | 1.27 | 0.88 | 0.99 | 0.94 |
| SG&A to Revenue | 0.59 | 0.99 | 0.27 | 0.26 | 0.40 |
| Stock-Based Compensation to Revenue | 0.12 | 0.13 | 0.14 | 0.29 | 0.33 |
| Income Quality | 0.64 | 0.48 | 0.93 | 0.76 | 1.00 |
Currency in USD
